Menu

Continued Fallout from Macchiarini Misconduct

The sacked researcher and surgeon was not properly vetted by the Swedish institutions that hired him in 2010, according to an independent review panel. 

Sep 7, 2016
Bob Grant

PIXABAY, DEBORABALVESThe swath of destruction caused by the alleged misconduct and fraud of surgeon Paolo Macchiarini continues to widen, as an independent panel reviews his case. In a report released last week (August 31), investigators commissioned by the Karolinska University Hospital—where Macchiarini used to work—stated that both the hospital and the Karolinska Institute (KI) failed to heed warning signs that the artificial organ researcher’s skill and professionalism was not up to par with the reputation he had cultivated in the popular press.

“Macchiarini was recruited as a senior physician at the hospital even though there were strongly critical opinions from his previous employers,” the investigators wrote. “Group thinking, bandwagon effects, a very competitive care environment, many informal leaders and deficient knowledge of and respect for rules are some of the factors that may have contributed to the course of events.”

Two KI officials are suffering backlash from the Macchiarini case. Anders Hamsten, who had already resigned from the institute’s vice-chancellor position over his role in hiring Macchiarini, and Harriet Wallberg, who was president of KI when the surgeon was hired, were both dismissed from the panel that awards Nobel Prizes for Medicine, according to The Guardian. In addition, Wallberg was fired from her post as the chancellor of the Swedish Higher Education Authority on Monday (Sept 5).

Several investigations have probed the Macchiarini case, which involved three artificial trachea implantations he performed while at KI. The researcher’s employment was terminated by the hospital in late 2013, and KI followed suit in March of this year. The most recent investigation echoed allegations of misconduct, including Macchiarini’s apparent failure to secure appropriate and informed consent, provide for his patient’s safety, or obtain necessary ethical clearance for the operations. Macchiarini has maintaned his innocence throughout.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.